• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿拉伯国家多发性硬化症的发病率及临床模式:一项系统评价

Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review.

作者信息

Benamer Hani T S, Ahmed Elfatih S M, Al-Din Amir S, Grosset Donald G

机构信息

Neurology Department, New Cross Hospital, Wolverhampton, UK.

出版信息

J Neurol Sci. 2009 Mar 15;278(1-2):1-4. doi: 10.1016/j.jns.2008.12.001. Epub 2009 Jan 9.

DOI:10.1016/j.jns.2008.12.001
PMID:19135686
Abstract

The susceptibility of various populations to multiple sclerosis (MS) and the clinical patterns of the disease are thought to be different. Nineteen articles related to incidence, prevalence and clinical patterns of MS in Arab populations were identified by keyword searching of Medline and Embase, and review of references in all relevant papers. Data were only available for the Kuwaiti, Jordanian, Libyan, Saudi, Iraqi, Palestinian (including Arabs living in Israel), and Omani populations. The publications ranged from 1975 to 2007. In Israel the incidence of MS was 0.7 per 100,000 per year in Arabs born and living in Greater Jerusalem. In Kuwait, the incidence of MS was 2.08 per 100,000. Prevalence varied from 4 to 42 per 100,000 population. The clinical pattern of MS was generally similar to that in western countries. However, one study from Oman found a high rate of optic-spinal disease (affecting one third of patients) and a low rate of oligoclonal bands (OGBs) (only one third of patients); this pattern resembles that of MS described in Asian countries. In conclusion, the prevalence of MS among Arabs has a wide reported range. The clinical pattern is generally similar to "Western type" MS but apparent differences in optic-spinal disease and OGBs positivity need further evaluation. There is significant opportunity for further evaluation of MS in Arabs, especially in unstudied areas, including the populous countries of Egypt, Algeria, Syria, and Morocco. Studies of Arab-Americans and Arab immigrants in Europe could help in defining the effect of immigration on MS. Such studies are likely to enhance our knowledge of the environmental, genetic and clinical variation of MS in Arabs.

摘要

不同人群对多发性硬化症(MS)的易感性以及该疾病的临床模式被认为存在差异。通过对Medline和Embase进行关键词搜索,并查阅所有相关论文的参考文献,共识别出19篇关于阿拉伯人群中MS发病率、患病率及临床模式的文章。数据仅适用于科威特、约旦、利比亚、沙特、伊拉克、巴勒斯坦(包括生活在以色列的阿拉伯人)和阿曼人群。这些出版物的时间跨度为1975年至2007年。在以色列,出生并生活在大耶路撒冷地区的阿拉伯人中,MS的发病率为每年每10万人中有0.7例。在科威特,MS的发病率为每10万人中有2.08例。患病率在每10万人中从4例到42例不等。MS的临床模式总体上与西方国家相似。然而,阿曼的一项研究发现视神经脊髓疾病的发生率较高(影响三分之一的患者),而寡克隆带(OGBs)的发生率较低(仅三分之一的患者);这种模式类似于亚洲国家所描述的MS。总之,阿拉伯人群中MS的患病率报道范围很广。临床模式总体上与“西方型”MS相似,但视神经脊髓疾病和OGBs阳性方面的明显差异需要进一步评估。对阿拉伯人群中的MS进行进一步评估有很大机会,特别是在未研究的地区,包括人口众多的埃及、阿尔及利亚、叙利亚和摩洛哥等国家。对阿拉伯裔美国人以及欧洲的阿拉伯移民进行研究,可能有助于确定移民对MS的影响。此类研究可能会增进我们对阿拉伯人群中MS的环境、遗传和临床变异的了解。

相似文献

1
Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review.阿拉伯国家多发性硬化症的发病率及临床模式:一项系统评价
J Neurol Sci. 2009 Mar 15;278(1-2):1-4. doi: 10.1016/j.jns.2008.12.001. Epub 2009 Jan 9.
2
Stroke in Arab countries: a systematic literature review.阿拉伯国家的中风:一项系统的文献综述。
J Neurol Sci. 2009 Sep 15;284(1-2):18-23. doi: 10.1016/j.jns.2009.04.029. Epub 2009 May 9.
3
Siponimod for multiple sclerosis.西尼莫德用于多发性硬化症。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013647. doi: 10.1002/14651858.CD013647.pub2.
4
Women's experiences throughout the birthing process in health facilities in Arab countries: a systematic review.阿拉伯国家医疗机构中女性分娩经历的系统评价。
Reprod Health. 2022 Mar 18;19(1):68. doi: 10.1186/s12978-022-01377-y.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.迟发性多发性硬化症的临床特征:系统评价和荟萃分析。
Mult Scler Relat Disord. 2021 May;50:102816. doi: 10.1016/j.msard.2021.102816. Epub 2021 Feb 4.

引用本文的文献

1
Incidence and prevalence of neurological disorders in the United Arab Emirates: a systematic review.阿联酋神经障碍的发生率和流行率:一项系统综述。
BMC Neurol. 2023 Nov 3;23(1):396. doi: 10.1186/s12883-023-03446-6.
2
Characteristics of Optic Neuritis in South Korean Children and Adolescents: A Retrospective Multicenter Study.韩国儿童和青少年视神经炎的特征:一项回顾性多中心研究。
J Ophthalmol. 2022 Sep 7;2022:4281772. doi: 10.1155/2022/4281772. eCollection 2022.
3
Clinical Profile and the Extent of Disability in Multiple Sclerosis Patients in Madinah, Saudi Arabia.
沙特阿拉伯麦地那多发性硬化症患者的临床概况与残疾程度
Cureus. 2022 Jun 11;14(6):e25851. doi: 10.7759/cureus.25851. eCollection 2022 Jun.
4
Socioeconomic determinants of global distribution of multiple sclerosis: an ecological investigation based on Global Burden of Disease data.社会经济因素对多发性硬化全球分布的影响:基于全球疾病负担数据的生态研究
BMC Neurol. 2021 Apr 1;21(1):145. doi: 10.1186/s12883-021-02170-3.
5
Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.多发性硬化症患者的遗传与分子生物学:综述。
Cell Mol Neurobiol. 2020 Jan;40(1):65-85. doi: 10.1007/s10571-019-00731-2. Epub 2019 Sep 3.
6
Cognitive Assessment of Individuals with Multiple Sclerosis in the Arab World: a Systematic Review.阿拉伯世界多发性硬化症患者认知评估的系统评价。
Neuropsychol Rev. 2019 Sep;29(3):259-269. doi: 10.1007/s11065-019-09408-5. Epub 2019 May 17.
7
Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea.韩国视神经炎与视神经脊髓炎谱系障碍及多发性硬化症的关联
Korean J Ophthalmol. 2019 Feb;33(1):82-90. doi: 10.3341/kjo.2018.0050.
8
Incidence and timing of recurrence of optic neuritis.视神经炎的复发率及复发时间
Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):651-655. doi: 10.1007/s00417-018-04217-7. Epub 2019 Jan 5.
9
Optic neuritis, the most common initial presenting manifestation of multiple sclerosis in northern Iran.视神经炎是伊朗北部多发性硬化最常见的初始表现形式。
Caspian J Intern Med. 2015 Summer;6(3):151-5.
10
Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.阿曼一家三级护理医院中多发性硬化症患者焦虑和抑郁的程度及并发情况。
BMC Neurol. 2015 Aug 5;15:131. doi: 10.1186/s12883-015-0370-9.